Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Big Data Analytics for Prostate Radiotherapy.

Coates J, Souhami L, El Naqa I.

Front Oncol. 2016 Jun 14;6:149. doi: 10.3389/fonc.2016.00149. eCollection 2016. Review.

2.

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions.

Laine AM, Pompos A, Timmerman R, Jiang S, Story MD, Pistenmaa D, Choy H.

Front Oncol. 2016 Jan 11;5:302. doi: 10.3389/fonc.2015.00302. eCollection 2015. Review.

3.

Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.

Yeo I, Nookala P, Gordon I, Schulte R, Barnes S, Ghebremedhin A, Wang N, Yang G, Ling T, Bush D, Slater J, Patyal B.

Radiat Oncol. 2015 Oct 24;10:213. doi: 10.1186/s13014-015-0522-5.

4.

Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts.

Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA.

Rev Urol. 2014;16(2):67-75.

5.

Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.

Habl G, Hatiboglu G, Edler L, Uhl M, Krause S, Roethke M, Schlemmer HP, Hadaschik B, Debus J, Herfarth K.

BMC Cancer. 2014 Mar 19;14:202. doi: 10.1186/1471-2407-14-202.

6.

Prostate cancer: current treatment and prevention strategies.

Chen FZ, Zhao XK.

Iran Red Crescent Med J. 2013 Apr;15(4):279-84. doi: 10.5812/ircmj.6499. Epub 2013 Apr 5. Review.

7.

Clinical controversies: proton therapy for prostate cancer.

Mouw KW, Trofimov A, Zietman AL, Efstathiou JA.

Semin Radiat Oncol. 2013 Apr;23(2):109-14. doi: 10.1016/j.semradonc.2012.11.009. Review.

8.

The clinical case for proton beam therapy.

Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB.

Radiat Oncol. 2012 Oct 22;7:174. doi: 10.1186/1748-717X-7-174. Review.

9.

Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer.

Johansson S, Aström L, Sandin F, Isacsson U, Montelius A, Turesson I.

Prostate Cancer. 2012;2012:654861. doi: 10.1155/2012/654861. Epub 2012 Jul 8.

10.

A review of update clinical results of carbon ion radiotherapy.

Tsujii H, Kamada T.

Jpn J Clin Oncol. 2012 Aug;42(8):670-85. doi: 10.1093/jjco/hys104. Epub 2012 Jul 13. Review.

11.

Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images.

Wang Y, Efstathiou JA, Sharp GC, Lu HM, Ciernik IF, Trofimov AV.

Med Phys. 2011 Aug;38(8):4623-33.

12.

Late gastrointestinal toxicities following radiation therapy for prostate cancer.

Kim S, Shen S, Moore DF, Shih W, Lin Y, Li H, Dolan M, Shao YH, Lu-Yao GL.

Eur Urol. 2011 Nov;60(5):908-16. doi: 10.1016/j.eururo.2011.05.052. Epub 2011 Jun 12.

13.

Review of clinical experience with ion beam radiotherapy.

Jensen AD, Münter MW, Debus J.

Br J Radiol. 2011 Dec;84 Spec No 1:S35-47. doi: 10.1259/bjr/71511359. Epub 2011 Mar 22. Review.

14.

Particle radiation therapy for gastrointestinal malignancies.

Meyer JJ, Czito BG, Willett CG.

Gastrointest Cancer Res. 2007;1(4 Suppl 2):S50-9.

15.

Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants?

Newhauser WD, Giebeler A, Langen KM, Mirkovic D, Mohan R.

Phys Med Biol. 2008 May 7;53(9):2327-44. doi: 10.1088/0031-9155/53/9/009. Epub 2008 Apr 17.

16.

Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.

Trofimov A, Nguyen PL, Coen JJ, Doppke KP, Schneider RJ, Adams JA, Bortfeld TR, Zietman AL, Delaney TF, Shipley WU.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):444-53. Epub 2007 May 21.

17.

Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.

Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):620-9.

18.

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study.

Ganswindt U, Budach W, Jendrossek V, Becker G, Bamberg M, Belka C.

Radiat Oncol. 2006 Apr 10;1:9.

19.

Proton beam therapy.

Levin WP, Kooy H, Loeffler JS, DeLaney TF.

Br J Cancer. 2005 Oct 17;93(8):849-54. Review.

Items per page

Supplemental Content

Write to the Help Desk